Meetings and Events

New12 April 2017 Multistakeholder brainstorming meeting: “Pancreatic cancer research priorities in Europe”
Brussel, Belgium

The purpose of this meeting was to perform a global scale analysis of pancretatic cancer research unmet needs to assess the actions needed to be done in Europe. Several EUPancreas members and Pancreatic Cancer Europe (PCE) Multistakeholders were invited to discuss on this issue during this Brainstorming Meeting.

Debates were held around the identification and prioritization of the main aspects to address in pancreatic cancer research in Europe in accordance with the international scenario. Strategies to lobby to increase awareness on pancreatic cancer research needs and funding in Europe were also discussed.

A report summarizing the conclusions of the meeting, with a prioritized list of PC research areas and actions, was drafted.

+ Pancreatic cancer research needs report
+ Meeting agenda
+ Presentation 1
+ Presentation 2
+ Presentation 3
+ Presentation 4

28 – 29 October 2016 EFISDS meeting “Pancreatic cancer: Where are we now? & Where are we going?”
Cluj-Napoca, Romania romaniaThis second edition of the scientific workshop on pancreas cancer research and management included special sessions to dedicated to pancreatitis, precursor lesions of pancreatic cancer, pancreatic cancer, and surgical-related issues. Members of EUPancreas COST Action presented some of the latest advances on these issues.

Co-organizers of the meeting are EUpancreas, Romanian Pancreatic Club, Romanian Society of Surgery, PCE (pancreatic cancer Europe) & the University of Medicine in Cluj. Members of EUPancreas will be participating in sessions on omics contribution to disentangle the molecular complexity of pancreatic cancer, biomarkers development for diagnosing pancreatic cancer, PanINs in chronic pancreatitis, familial pancreatic cancer, PancreOS the European pancreatic cancer clinical registry, among others.

30 September 2016 EU Action on Pancreas Cancer
Gastein, Austria The EUPancreas COST Action aims to maximize through this event the impact of pancreatic cancer research on policy makers, regulatory bodies, national decision makers and the private sector. Key stakeholders from administration, academia, NGOs and industry will discuss how a European coordinated approach to combat pancreatic cancer via the COST Action „EUPancreas”. Experiences from the Action will be described to contribute to improving the management of this disease in European Reference Centers (ERCs).

+ More information

6 – 9 July 2016 WG3 meeting, MC meeting and 48th ANNUAL MEETING OF THE EUROPEAN PANCREATIC CLUB
Liverpool, UK

The annual meeting of European Pancreatic Club 2016 brings together diverse disciplines involved in the study of the exocrine and endocrine pancreas. Topics covered this year are Pancreatic Cancer: The place of surgery and local and systemic therapies, Cystic tumours, genetics and epigenetics of pancreatic diseases, pancreatic cancer: the stroma and inflammation, among many others of high scientific relevance.

The WG3 meeting (7th July) and aims to update work progress on the ongoing and the future planned activities. The 7th MC meeting will take place on 8th July.

+ Agenda WG3 meeting
+ Agenda MC meeting
+ Minutes MC meeting
+ More information

22 – 23 June 2016 European Pancreas Cancer Epidemiology Workshop and 2016 Pancreatic Cancer Case Control Consortium (PanC4) 
Milan, Italy panc4logo

The European Pancreas Cancer Epidemiology Worshop is an activity organized by WG1. It wishes to bring European epidemiologists interested in pancreas cancer together and to identify areas of common interest to potentiate pancreas cancer research as well as to lobby on this area in Europe and beyond.

The workshop contemplates presentations of projects and studies conducted by WG1 members. The Panc4 conference will focus on recent progress of the Consortium projects though specially emphasizing the role of infectious agents and microbioma in the aetiology of pancreas cancer, this including diabetes mellitus and obesity as its risk factors. To this end, a mini-symposium on this topic

“Microbiome and Pancreatic cancer” is planned.

+ Agenda WG1 meeting
+ Agenda Panc4 meeting
+ More information

3 – 7 May 2016 WG3 TRAINING SCHOOL on “GENOMIC MEDICINE – Bridging research and the clinic” jointly organized with ARTEMIDA, Golden Helix Institute of Biomedical Research Genomic Medicine Alliance
Portoroz, Slovenia event-2016-05-04Topics of interest to the Action such as oxidative stress, rare cancers, epidemiology, pathogenesis/pathology, and treatment modalities for pancreas cancer, as well as personalized medicine and public health will be among the topics of the school. ECIs will be specially welcome. In addition, a Satellite workshop “In vitro and in vivo models for development of novel diagnostic and therapeutic approaches” will take place on May 3rd 2016.

Please note the important dates:

  • March 15th 2016 – early registration deadline
  • April 11th 2016 – abstract submission deadline

This event is intended to enlarge the EUPancreas membership in COST Inclusiveness Countries; to enhance pancreas cancer research in Europe; to train members, especially, ECIs, and to disseminate EUPancreas activities and results.

Program updates and travel information:
+ Program
+ Application (first)
+ More information
+ Link to the official training school website

More information at training school section

27 – 29 April 2016 WG2 TRAINING SCHOOL on Interactions in Complex Disease Analysis. The world of interactions around us, co-organized by Antwerp University (Joost Weyler and Kristel Sleegers) and co-sponsored by the Belgian Society of Statistics
Antwerp, Belgium The school will cover the different scenarios of data analysis where interaction needs to be assessed. An introduction on what interactions are and are not in addition to deal with gene*gene and gene*environment interactions will be given. A hands-on with examples and practical training is also planned.Objectives of the event are to train members, especially ECIs, in statistics on omics data interaction assessment; to create a network of members expert in statistics to be applied to pancreas cancer research in different countries of EU; to increase the EUPancreas membership; and to disseminate on the EUPancreas activities. The Agenda of the Training School will be distributed in due time.
+ Location (map)
+ New Program & Accomodation
+ Application (first)
+ RegistrationMore information at training school section
5 – 7 April 2016 WG4 – Patient Management STAKEHOLDER AND DISSEMINATION MEETINGS in the 4th European Alliance for Personalised Medicine (EAPM) Annual Conference.
Brussel, Belgium eapm-fotoMembers of WG4 participated in this 4th edition of the EAPM Annual Conference. A two-day series of roundtables were held to discuss about the need for rising awareness on personalized medicine integration at European and national levels.
+ more information
17 March 2016 WG4/WG1 – PancreOS (the European Pancreatic Cancer Registry) kick-off meeting
Madrid, Spain PancreOsLeafletThe PancreOs kick-off meeting was held to discuss about the implementation of the PancreOS registry in Europe. PancreOS is intended to be a solid data base of pancreatic cancer, which will make available regular information on the burden and clinical management of pancreatic cancer in Europe. It is supported by several organisations, including the BM1204 COST Action EUPancreas, the European Network of cancer registries (ENCR) and Pancreatic Cancer Europe (PCE).
+ more information
5-7 November 2015 ANNUAL CONFERENCE, WG MEETINGS, MC MEETING JOINT WORKSHOP WITH UEG, EPC, EFISDS, and EAPM ON: “Burning Issues in Pancreatology”
Cluj-Napoca, Romania Cluj-Napoca, RomaniaThe scientific workshop sessions on Friday and Saturday will cover emerging needs for pancreas cancer research and management as well as aspects related to acute and chronic pancreatitis, precursor lesions of pancreatic cancer, pancreatic cancer, and surgical-related issues. EUPancreas is actively participating in the organization of this event and has planned a three Roundtable on Evidences from epidemiology on pancreas cancer etiologic factors, Omics contribution to disentangle the molecular complexity of pancreatic cancer, and Personalized medicine for pancreatic cancer, the latter one is co-organized jointly with the European Alliance for Personalized Medicine. The participation of ECIs is specially promoted promoted since parallel courses are being organized such one on laparoscopic surgical skills planned by the Dutch Society.Reviewing and prioritizing the goals and activities for each WG as well as for the whole Action as well as to plan the activities for the 4 Grant Period are among the objectives of this Event.
EUPancreas Annual Conference, WGs meetings and MC meeting meeting will take place after the workshop.
+ agenda WG meeting
+ agenda MC meeting
+ more information web and .pdf
+ Minutes WG meeting
+ Minutes MC meeting
10 – 15 September 2015 WG4 TRAINING SCHOOL on ”Genomics and Genthics” ORGANIZED JOINTLY WITH CHIP-ME COST ACTION (IS1303), the European Society for Pharmacogenomics and Theranostics, and Golden Helix Genomic Medicine Alliance.
Aegina, Greece The School will be an opportunity for postgraduate, postdoctoral or established researchers, as well as other suitably qualified individuals working in the relevant academic and non-academic fields, to avail of a mixture of cutting-edge lectures and interactive sessions in the following areas: 1) Translating genomic research to genomic medicine; 2) Direct to consumer genetic testing: scientific, legal and ethical concerns; 3) Incidental findings and informed consent; 4) Genomics in developing countries Genomics, markets and justice/inequality; 5) Economics of genomic medicine and health technology assessment; 6) Intellectual property in genomics; and 7) Policymaking, public engagement and genetic literacy.EUPancreas organizes a focussed pancreas cancer session on September 15 entitled: “Public-Private challenges in pancreas research, policy, and practice ”Objectives of the School are fostering interactions accross Actions and between academic and non-academic organizations; Increasing awareness of pancreas cancer, its need of research, as well as on EUPancreas; and training EUPancreas members, specially ECIs.

+ Information pack
+ Agenda

1st July 2015 WG2 – OMICS INTEGRATION IN PDAC WORKSHOP: Cancer genomics and personalised medicine workshop: focus on pancreas cancer”.
Barcelona, Spain This workshop will offer examples of the application of omics in pancreatic cancer with the ultimate goal of enhancing pancreatic cancer care and the prevention of this disease. Other objectives are to identify emerging groups working on omics data analysis and foster collaborations between them and PDAC omics data generating groups; to look for available omics data on PDAC and evaluate the possibility to pool them; to train members, specially ECIs; and to increase awareness on pancreas cancer research and EUPancreas.
Organizers

  • Núria López-Bigas (Universitat Pompeu Fabra, Barcelona)
  • Stephan Ossowski (Centre for Genomic Regulation, Barcelona)
  • Kristel Van Steen (University of Liege, Belgium)

Confirmed Speakers

  • Ben Raphael (Brown University, USA)
  • David Chang (Institute of Cancer Sciences, University of Glasgow)
  • Stephan Ossowski (Centre for Genomic Regulation, Barcelona)
  • Sílvia Pineda (Spanish National Cancer Research Centre, Madrid)
  • Elena Gusareva (University of Liege, Belgium)

A WG2 meeting will take place after the workshop.

+ preliminar agenda

23 – 26 June 2015 WG1, WG2, WG3 and WG4 Joint Meeting + MC Meeting + Stakeholder meetings organized with the 47th ANNUAL MEETING OF THE EUROPEAN PANCREATIC CLUB.
Toledo, Spain
The Joint WGs meeting aims at sharing information and challenges on the ongoing and the future planned activities within each WG with all the Action members as well as to enhance the cross-WG interactions.
The 5th MC meeting will take place after the joint WGs meeting.The annual meeting of European Pancreatic Club 2015 brings together diverse disciplines involved in the study of the exocrine and endocrine pancreas. EUPancreas has been involved in the organization of the EPC2015 meeting and actively participate in the following activities:

  1. Several EPC2015 SC members are members of the EUPancreas Action (Chair/President)
  2. Several speakers in the EPC2015 meeting are members of the EUPancreas Action.
  3. Promoting ECIs (Early Career Investigators) EUPancreas and the EPC2015-YOUPPIE organization have awarded to abstracts of two ECIs that will be presented during Session 11: Simone Hausmann and (EUPancreas) and Nicolien Schepers (YOUPPIE).
  4. Increasing the awareness of pancreatic cancer and the Action activities in the following sessions:

– 24th June 2015. Round Table – Increasing pancreas cancer awareness in Europe. Supported by “Pancreatic Cancer UK” and EUPancreas.

event-2015-06

– 26th June 2015. 2nd EU Multi-Stakeholder Platform on Pancreatic Cancer. Members of the EUPancreas COST Action are working on the 3 workstreams currently ongoing: diagnosis, disease registries and awareness.

+ detailed information
+ website of the congress
Agenda MC meeting
+ Minutes WG meeting
+ Minutes MC meeting

18 June 2015 Patient Management STAKEHOLDER AND DISSEMINATION MEETINGS in the Big Dada Value Association Summit – Healthcare Session.
Madrid, Spain The Action Chair participated in this event representing the COST Action EUPancreas BM1204 and presented in the Healthcare session  on “Getting the value of BD…The role of BD in Personalized Medicine”A brainstorming about the needs of big data in Healthcare followed.
2nd – 3rd June 2015 WG4 – Patient Management STAKEHOLDER AND DISSEMINATION MEETINGS in the 3rd European Alliance for Personalised Medicine (EAPM) Annual Conference.
Brussel, Belgium The Action Coordinator of WG4 on Patient Management and the Action Chair participated in this event, representing the COST Action EUPancreas BM1204 through two plenary sessions of this event:

  • Plenary Session V. Personalised medicine and a European Big Data-driven economy.
  • Plenary Session VI. Unlocking the value of research to provide evidence and education of healthcare professions to realize the benefits for today and tomorrow´s discoveries.

In these plenary sessions, the importance to develop and adequately resource a pancreatic cancer patient-centred European Translational Research Platform was highlighted through the COST Action.

+ more information: Press release
+ more information: Conference programme
+ video

27 April 2015 WG1 MEETING and PDAC BIOBANKING WORKSHOP organized jointly with the Institute of Pathology of The University of Heidelberg
Madrid, Spain Members from different workgroups of COST Action BM1204 visited the NCT and EPZ biobanks and were informed by the biobank leaders, Esther Herpel (NCT) and Nathalia Giese (EPZ), about organizational features, protocols and standard operating procedures that are in place at these facilities.
+ agenda
+ presentation
26 – 27 March 2015 WG3 MEETING
Liverpool, UK The meeting with 18 WG3 members cover aspects of the 3 main workstreams of the group: Risk population, Cystic tumour, and New onset diabetes collection, identifying challenges and planning for the next steps towards a H2020 application.
+ minutes
4 – 6 December 2014 WG1 TRAINING SCHOOL ON “PATHOLOGY OF THE EXOCRINE PANCREAS – OF MICE AND MEN”
Madrid, Spain This 3-day “meet the expert” course was held in the Spanish National Cancer Research Centre (CNIO), Madrid.
Faculty

  • Irene Esposito (Pathologie der Medizinischen Universität Innsbruck)
  • Fiona Campbell (Royal Liverpool University Hospital)
  • Paola Martinelli (Universität Wien)
  • Paulina Gómez (Spanish National Cancer Research Centre)
  • Alba de Martino (Spanish National Cancer Research Centre)
  • Francisco Real (Spanish National Cancer Research Centre)

+ poster
+ detailed information

24 – 26 November 2014 Annual Conference, WG1, WG2, WG3 and WG4 Meetings, MC Meeting and Conference “CAPITA SELECTA IN COMPLEX DISEASE ANALYSIS”
Liege, Belgium The focus of the third edition of Capita Selecta in Complex Disease Analysis CSCDA2014 was on:
I. Population and patient heterogeneity
II. Data fusion and omics integration for rare diseases.
WGs individual meetings and the 4th MC meeting were held during the Conference.
+ detailed information
+ website of rhe congress
+ WG1 meeting Minutes
+ WG2 meeting Minutes
+ WG3 meeting Minutes
+ WG4 meeting Minutes
+ MC meeting Minutes
3 October 2014 Patient Management STAKEHOLDER AND DISSEMINATION MEETINGS in the Cystic Tumours of the Pancreas: Patient & Public Forum
London, UK Several EUPancreas members participated and presented in this event representing the COST Action EUPancreas BM1204.
+ agenda
24 – 28 June 2014 3rd Management Committee Meeting + IPMN Session organized in the 46th ANNUAL MEETING OF THE EUROPEAN PANCREATIC CLUB
University of Southampton Southampton. UK University of Southampton Southampton. UKAn ad-hoc EUPancreas session on IPMN held on Thursday 26 June and chaired by FX Real dealt with the following topics:

  • Modeling IPMN Subtypes using Genetic Engineered Mice (Jens Siveke, Technical University Munich)
  • Perspective of the Human IPMNs (Aldo Scarpa, University and Hospital Trust of Verona)

The 3rd MC meeting was held during the Conference on Wednesday 25 June 2014.

+ agenda
+ MC Minutes

20 May 2014 3rd WG1 meeting
Mario Negri Institute. Milan, Italy WG1 members met to report on the progress of the WG1 initiatives, identify challenges and plan for the future work.
+ WG1 meeting Minutes
1 – 2 May 2014 WG3 Meeting and LONDON PANCREAS WORKSHOP 2014
A forum for state of the art clinical and basic research in pancreatic cancer
London, UK The London Pancreas Workshop was launched in 2006 and now convenes every two years. The Workshop attracts delegates from the UK and abroad, comprising of clinicians (surgeons, gastroenterologists, radiologists, pathologists, oncologists amongst others), scientists, pharmaceutical company representatives and pancreatic cancer charity representatives. A wide range of topics relating to pancreatic cancer clinical and scientific problems are discussed and progress updates presented.
+ agenda
+ minutes
14 February 2014 WG2 Meeting and Workshop on “omics integration”
Heidelberg, Germany This workshop was held at the Funcional Genome Analysis Unit of the German cancer reserch center DFKZ. (Deutsches Krebsforschungszentrum). The workshop focused on the integration of heterogeneous and large omics data for pancreatic cancer research through novel data integration methodologies, and available biological data sources. A WG2 meeting was held after the Workshop.
+ Program
+ WG2 Minutes
28 – 30 November 2013 First EUPancreas Annual Conference, WGs Meetings, MC meeting in the Pancreas Cancer Forum 2013
CNIO&CIOCC. Madrid, Spain The first Annual meeting of the ActionWGs independent meetings were held on the 28-29 November 2013
WG1 Minutes
WG2 Minutes kick-off meeting
WG2 Minutes 1st meeting
WG3 Minutes
WG4 Minutes kick-off and 1st meeting
The 2nd MC meeting was held on 30 November 2014
Minutesevents-2014-11-3During the meeting, leading oncologists and researchers reviewed the latest research into the pathogenesis, prognosis and management of pancreatic cancer.  In particular, the forum aimed to place preclinical, molecular and translational advances into a clinical context for the audience of oncologists from across Europe.+ Program
13 June 2013 WG1 kick-off meeting. Spanish National Cancer Research Center (CNIO)
Madrid, Spain Minutes kick-off meeting
17 June 2013 WG3 kick-off meeting
Bochum University
Bochum, Germany Minutes kick-off meeting
14 December 2012 EUPancreas kick-off meeting. 1st Management Committee Meeting
COST Headquarters
Brussels, Belgium + Minutes kick-off meeting MC